您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (9): 115-124.doi: 10.6040/j.issn.1671-7554.0.2024.0603

• 主动脉疾病基础与临床研究进展专刊—临床研究 • 上一篇    

原发性主动脉血栓形成诊治单中心经验

王潇晗1,吴学君1,董典宁1,王茂华1,韩宗霖1,高培显1,孔祥骞1,2   

  1. 1.山东第一医科大学附属省立医院血管外科, 山东 济南 250021;2.山东大学附属省立医院血管外科, 山东 济南 250021
  • 发布日期:2024-10-10
  • 通讯作者: 孔祥骞. E-mail:xiangqian168@163.com
  • 基金资助:
    国家自然科学基金(82371594);山东省自然科学基金(ZR2021MH281);泰山学者青年专家基金(tsqn202211329)

Single-center experience in diagnosis and treatment of primary aortic thrombosis

WANG Xiaohan1, WU Xuejun1, DONG Dianning1, WANG Maohua1, HAN Zonglin1, GAO Peixian1, KONG Xiangqian1,2   

  1. 1. Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China;
    2. Department of Vascular Surgery, Shandong Provincial Hospital, Shandong University, Jinan 250021, Shandong, China
  • Published:2024-10-10

摘要: 目的 探究原发性主动脉血栓形成(primary aortic thrombosis, PAT)的诊治方法及预后。 方法 回顾性收集2017年1月至2023年12月于山东第一医科大学附属省立医院血管外科接受治疗的21例PAT患者的临床数据,包括性别、年龄、合并症、术前临床及辅助检查资料等,总结其临床特点、治疗方案及随访预后等信息。 结果 纳入21例PAT患者首发症状均为肢体或内脏缺血,其中包括Ⅱ型7例,Ⅲ型2例,Ⅳ型9例,Ⅱ+Ⅲ型1例,Ⅱ+Ⅳ型1例,Ⅲ+Ⅳ型1例。所有患者入院后均进行规范抗凝治疗,其中15例患者接受手术取栓或胸主动脉腔内修复术(thoracic endovascular aortic repair, TEVAR),术后接受长期抗凝、抗血小板治疗;6例患者全程抗凝、抗血小板治疗,未行手术。中位随访时间18个月,随访期间1例患者出现下肢缺血症状,2例患者死亡,其他患者未诉不适,未再发内脏或下肢缺血。 结论 对于无法确定栓子来源的急性肢体或内脏缺血,应当考虑PAT;发现PAT,若无抗凝禁忌,应全程抗凝治疗,普通肝素持续泵入效果可能优于低分子肝素;TEVAR对于预防再发栓塞有意义,术后应严格定期复查,动态观察PAT的病变,避免再次栓塞事件的发生。

关键词: 原发性主动脉血栓形成, 动脉栓塞, 主动脉腔内修复术, 取栓术, 抗凝治疗

Abstract: Objective To explore the diagnosis, treatment and prognosis of primary aortic thrombosis(PAT). Methods Clinical data from 21 patients with PAT treated in the Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University from January 2017 to December 2023 were retrospectively collected, including gender, age, comorbidities, preoperative and auxiliary examination data, to summarize the information on their clinical characteristics, treatment plan, and follow-up prognosis. Results The first symptom of all the 21 patients was limb or visceral ischemia, including 7 cases of type Ⅱ, 2 cases of type Ⅲ, 9 cases of type Ⅳ, 1 case of type Ⅱ+Ⅲ, 1 case of type Ⅱ+Ⅳ and 1 case of type Ⅲ+Ⅳ. All patients underwent standardized anticoagulation therapy after admission. Among them, 15 patients received surgical thrombectomy or thoracic endovascular aortic repair(TEVAR)and long-term anticoagulant and antiplatelet therapy after surgery, and 6 patients underwent complete anticoagulation and antiplatelet therapy without operation. The median follow-up time was 18 months. During the follow-up period, 1 patient developed symptoms of lower limb ischemia, 2 patients died, and the rest of the patients did not complain of discomfort and did not suffer from recurrence of visceral or lower limb ischemia. Conclusions PAT should be considered for acute limb or visceral ischemia when the source of embolus cannot be determined. If PAT is found, anticoagulation therapy should be applied throughout the course unless there are contraindications to anticoagulation. Continuous pumping of ordinary heparin may have a better effect than low-molecular-weight heparin. TEVAR is significant for the prevention of recurrent embolization, and the postoperative periodical review should be strict, and dynamic observation of PAT lesions should be carried out, so as to avoid reembolism events.

Key words: Primary aortic thrombosis, Arterial embolism, Endovascular aortic repair, Thrombectomy, Anticoagulant therapy

中图分类号: 

  • R543.1
[1] Gaylis H. Primary aortic thrombosis[J]. Circulation, 1958, 17(5): 941-944.
[2] Martins APD, Bertolucci LH, Warpechowski RB, et al. Mobile thrombus of the abdominal aorta: a narrative review[J]. J Vasc Bras, 2022, 21: e20220028. doi:10.1590/1677-5449.202200282.
[3] 何长顺, 张韬, 李清乐, 等. 原发性主动脉壁血栓的诊疗进展[J]. 中国普通外科杂志, 2019, 28(8): 1007-1011. HE Changshun, ZHANG Tao, LI Qingle, et al. Progress in diagnosis and treatment of primary aortic mural thrombus[J]. Chinese Journal of General Surgery, 2019, 28(8): 1007-1011.
[4] Tsilimparis N, Hanack U, Pisimisis G, et al. Thrombus in the non-aneurysmal, non-atherosclerotic descending thoracic aorta: an unusual source of arterial embolism[J]. Eur J Vasc Endovasc Surg, 2011, 41(4): 450-457.
[5] Machleder HI, Takiff H, Lois JF, et al. Aortic mural thrombus: an occult source of arterial thromboembolism[J]. J Vasc Surg, 1986, 4(5): 473-478.
[6] Jiang H, Huang C, Shi Y, et al. Effect of smoking on thrombotic antiphospholipid syndrome: a 10-year prospective cohort study[J]. Rheumatology, 2024, 63(7): 1917-1922.
[7] 邵江, 孔德强, 李康, 等. 多学科综合治疗协作组诊治原发性主动脉附壁血栓致腹主动脉骑跨栓[J]. 中华普通外科杂志, 2023, 38(7): 540-543. SHAO Jiang, KONG Deqiang, LI Kang, et al. Diagnosis and treatment of abdominal aortic straddling thrombosis caused by primary aortic attached thrombosis in multidisciplinary comprehensive treatment cooperative group[J]. Chinese Journal of General Surgery, 2023, 38(7): 540-543.
[8] 张强, 游国超, 徐化静, 等. 主动脉原发性血栓的诊断及治疗[J]. 中华血管外科杂志, 2022, 7(4): 261-268. ZHANG Qiang, YOU Guochao, XU Huajing, et al. Diagnosis and therapy for primary aorticmural thrombus[J]. Chinese Journal of Vascular Surgery, 2022, 7(4): 261-268.
[9] McGuinness B, Goel A, Chen J, et al. The association of cannabis use disorder with acute limb ischemia and critical limb ischemia[J]. Vascular and Endovascular Surgery, 2022, 56(5): 480-494.
[10] Matsumoto Y, Horimasu Y, Yamaguchi K, et al. D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: a case report[J]. Medicine, 2021, 100(7): e24695. doi:10.1097/MD.0000000000024695.
[11] Mendes D, Veiga C, Machado R, et al. The challenge of managing a primary aortic mural thrombus: outcomes and technical considerations[J]. The International Journal of Angiology: Official Publication of the International College of Angiology, Inc, 2024, 33(3): 156-164.
[12] Khalil A, Kanitra JJ, Lorelli D. Non-diseased aortic mural thrombus presenting with acute limb ischaemia[J]. BMJ case reports, 2022, 15(3): e247297. doi: 10.1136/bcr-2021-247297.
[13] Fayad ZY, Semaan E, Fahoum B, et al. Aortic mural thrombus in the normal or minimally atherosclerotic aorta[J]. Ann Vasc Surg, 2013, 27(3): 282-290.
[14] Choukroun EM, Labrousse LM, Madonna FP, et al. Mobile thrombus of the thoracic aorta: diagnosis and treatment in 9 cases[J]. Ann Vasc Surg, 2002, 16(6): 714-722.
[15] Nguyen Q, Ma X, Vervoort D, et al. Management strategies for descending thoracic aortic thrombus: a review of the literature[J]. Innovations(Philadelphia, Pa.), 2022, 17(4): 283-296.
[16] Tenenbaum A, Motro M, Shapira I, et al. Fluid dynamics and atherosclerosis development in the human thoracic aorta: a transesophageal echocardiographic evaluation of protruding aortic plaque distribution and motion[J]. J Med, 2000, 31(1/2): 63-76.
[17] 张强, 李晓光, 游国超, 等. 腔内治疗原发性主动脉血栓10例[J]. 介入放射学杂志, 2023, 32(4): 330-337. ZHANG Qiang, LI Xiaoguang, YOU Guochao, et al. Endovascular therapy for primary aortic mural thrombus in ten patients [J]. Journal of Interventional Radiology, 2023, 32(4): 330-337.
[18] Akcelik A, Minakata K, Sunagawa G, et al. Surgical management of primary aortic thrombus in thoracic aorta[J]. JTCVS open, 2023, 16: 84-92. doi:10.1016/j.xjon.2023.09.022.
[19] Sousa P P, Pinto P S. Endovascular treatment of a symptomatic thoracic aorta thrombi[J]. Rev Port Cir Cardiotorac Vasc, 2020, 27(3): 227-230.
[20] Vaidya YP, Schaffert TF, Shaw PM, et al. Management of mobile thrombus of the thoracic aorta[J]. J Vasc Surg Cases Innov Tech, 2021, 7(4): 627-629.
[21] Grassl K, Hangler H, Gratl A, et al. A free-floating aortic Thrombus: an uncommon approach to handle a rare clinical entity[J]. J Endovasc Ther, 2024. doi:10.1177/15266028241256817.
[22] 石静, 谢军, 陈颍, 等. Fogarty球囊导管取栓联合双侧髂动脉球囊阻断术治疗急性肾动脉血栓1例[J]. 介入放射学杂志, 2021, 30(10): 1077-1078. SHI Jing, XIE Jun, CHEN Ying, et al. Fogarty balloon catheter thrombectomy combined with bilateral iliac artery balloon occlusion for acute renal artery thrombosis: report of one case[J]. Journal of Interventional Radiology, 2021, 30(10): 1077-1078.
[23] Esposito D, Gonfiantini F, Fargion AT, et al. Hybrid operating room applications in the increasingly complex endovascular era: the trump card of modern vascular surgery[J]. Ann Surg Treat Res, 2021, 100(1): 54-58.
[24] McClure RS, Berry RF, Dagenais F, et al. The many care models to treat thoracic aortic disease in Canada: a nationwide survey of cardiac surgeons, cardiologists, interventional radiologists, and vascular surgeons[J]. CJC Open, 2021, 3(6): 787-800.
[25] 张雨嫣, 付琴, 刁文杰, 等. 胸主动脉杂交手术的配合体会[J]. 中华全科医学, 2022, 20(11): 1978-1981. ZHANG Yuyan,FU Qin,DIAO Wenjie, et al. Experience in coordination in thoracic aortic hybrid surgery[J]. Chinese Journal of General Practice, 2022, 20(11): 1978-1981.
[1] 赵文鹏,吕凡振,胡义良,陈晒,方华强,王世知,周为民. Stanford B型主动脉壁间血肿单中心治疗经验[J]. 山东大学学报 (医学版), 2024, 62(9): 108-114.
[2] 张志炜,孟庆友,丁庆伟,张晓宇. 外科辅助短距离逆行针刺技术在主动脉弓原位开窗中的早期应用效果[J]. 山东大学学报 (医学版), 2024, 62(9): 93-100.
[3] 梁博文,陆清声. 机器人辅助主动脉腔内修复术的进展[J]. 山东大学学报 (医学版), 2024, 62(9): 61-65.
[4] 杨建平,管圣,方青波,慈红波,戈小虎. 钝性胸主动脉损伤的诊治进展[J]. 山东大学学报 (医学版), 2024, 62(9): 36-41.
[5] 王伦常,覃淇,舒畅. 创伤性B型主动脉夹层的诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 19-25.
[6] 卫任,郭伟. 腹主动脉瘤腔内治疗现状[J]. 山东大学学报 (医学版), 2024, 62(9): 13-18.
[7] 林长泼,符伟国. Stanford B型主动脉夹层的诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 7-12.
[8] 黄柏松,丛洪良. 1 430例中年中危血栓栓塞风险心房颤动抗凝治疗的方案[J]. 山东大学学报 (医学版), 2021, 59(10): 49-67.
[9] 霍素霞,刘薇,王鑫. 86例Ⅲ型瘢痕妊娠诊治体会[J]. 山东大学学报 (医学版), 2021, 59(1): 40-44.
[10] 田宁,陈奕,韩文莉,张晓峰. 盆腔动脉栓塞术治疗产后出血的临床分析[J]. 山东大学学报 (医学版), 2019, 57(12): 86-91.
[11] 刘敏,许小伟,杜文军. 肝硬化门脉高压合并脾动静脉瘘1例[J]. 山东大学学报(医学版), 2016, 54(7): 91-92.
[12] 段红永,管强,梁宁,杨笑非,韩锋,马明,刘增庆. 下肢动脉闭塞介入中发生远端栓塞的治疗经验[J]. 山东大学学报(医学版), 2016, 54(3): 55-58.
[13] 赵真,董白桦,苏士利. 102例剖宫产术后子宫瘢痕处妊娠治疗效果评价[J]. 山东大学学报(医学版), 2014, 52(1): 75-79.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!